MNPR financials

Monopar Therapeutics (MNPR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

MNPR income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$16.70M-$13.72M-1.85
2024––-$16.16M-$15.59M-4.11
2023––-$8.83M-$8.40M-3.04
2022––-$10.54M-$10.52M-4.15
2021––-$9.13M-$9.10M-3.65
2020––-$6.51M-$6.30M-2.90